276 related articles for article (PubMed ID: 29974177)
1. Imaging and staging of neuroendocrine cervical cancer.
Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P
Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177
[TBL] [Abstract][Full Text] [Related]
2. MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations.
Duan X; Ban X; Zhang X; Hu H; Li G; Wang D; Wang CQ; Zhang F; Shen J
Eur Radiol; 2016 Dec; 26(12):4293-4302. PubMed ID: 26995208
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence and survival in neuroendocrine cervical cancer.
Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
[TBL] [Abstract][Full Text] [Related]
7. Natural history and outcome of neuroendocrine carcinoma of the cervix.
Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865
[TBL] [Abstract][Full Text] [Related]
8. Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix.
Goto S; Terao Y; Kamigaki T; Takimoto R; Naitoh K; Makita K; Yasumoto K; Okada S; Takizawa K; Yokomichi N; Suzuki N; Takeda S
Anticancer Res; 2020 Aug; 40(8):4741-4748. PubMed ID: 32727800
[TBL] [Abstract][Full Text] [Related]
9.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
Zhu R; Wu H; Chen B; Pang J; Huo Z
Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
[TBL] [Abstract][Full Text] [Related]
11. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis.
Kim C; Salvo G; Ishikawa M; Chen TC; Jhingran A; Bhosale P; Ramalingam P; Frumovitz M
Gynecol Oncol; 2023 Mar; 170():328-332. PubMed ID: 36773379
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications.
Wang KL; Yang YC; Wang TY; Chen JR; Chen TC; Chen HS; Su TH; Wang KG
J Chemother; 2006 Apr; 18(2):209-16. PubMed ID: 16736891
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
[TBL] [Abstract][Full Text] [Related]
14. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
[TBL] [Abstract][Full Text] [Related]
15. Updates and management algorithm for neuroendocrine tumors of the uterine cervix.
Salvo G; Gonzalez Martin A; Gonzales NR; Frumovitz M
Int J Gynecol Cancer; 2019 Jul; 29(6):986-995. PubMed ID: 31263021
[TBL] [Abstract][Full Text] [Related]
16. PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.
Lai ZY; Yeo HY; Chen YT; Chang KM; Chen TC; Chuang YJ; Chang SJ
Oncotarget; 2017 Jul; 8(28):45323-45334. PubMed ID: 28484083
[TBL] [Abstract][Full Text] [Related]
17. Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract][Full Text] [Related]
18. Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer.
Zeng F; Tuo Y; Liu D; He M
J Obstet Gynaecol Res; 2020 Jun; 46(6):950-954. PubMed ID: 32266759
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment for neuroendocrine carcinoma of the uterine cervix.
Kasamatsu T; Sasajima Y; Onda T; Sawada M; Kato T; Tanikawa M
Int J Gynaecol Obstet; 2007 Dec; 99(3):225-8. PubMed ID: 17897648
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
